Clofazimine Soft Capsules
Generic name：Clofazimine Soft Capsules
Approval number：SFDA approval numberH32025617
Specifications：0.2g*8 tablet *3 piecess
Drug type：Prescription drugs
Main ingredients：
Cinametic acid (C12H14O5): 95.0%～105.0%
Detailed description
Clofazimine Soft Capsules, a national exclusive product, It is used in the treatment of multidrug-resistant tuberculosis (MDR -- TB) and extensively drug-resistant tuberculosis (XDR -- TB), and was successfully granted a patent certificate by the state in 2013. Due to its remarkable therapeutic effect in a wide range of clinical applications, it has attracted great attention from the state, and was supported by the national special fund in 2010.
